1. Home
  2. EYPT vs PDFS Comparison

EYPT vs PDFS Comparison

Compare EYPT & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • PDFS
  • Stock Information
  • Founded
  • EYPT N/A
  • PDFS 1992
  • Country
  • EYPT
  • PDFS United States
  • Employees
  • EYPT N/A
  • PDFS N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • PDFS EDP Services
  • Sector
  • EYPT Industrials
  • PDFS Technology
  • Exchange
  • EYPT Nasdaq
  • PDFS Nasdaq
  • Market Cap
  • EYPT 741.0M
  • PDFS 764.2M
  • IPO Year
  • EYPT N/A
  • PDFS N/A
  • Fundamental
  • Price
  • EYPT $14.01
  • PDFS $19.95
  • Analyst Decision
  • EYPT
  • PDFS Strong Buy
  • Analyst Count
  • EYPT 0
  • PDFS 3
  • Target Price
  • EYPT N/A
  • PDFS $33.33
  • AVG Volume (30 Days)
  • EYPT 659.8K
  • PDFS 327.2K
  • Earning Date
  • EYPT 08-06-2025
  • PDFS 08-07-2025
  • Dividend Yield
  • EYPT N/A
  • PDFS N/A
  • EPS Growth
  • EYPT N/A
  • PDFS N/A
  • EPS
  • EYPT N/A
  • PDFS 0.02
  • Revenue
  • EYPT $51,898,000.00
  • PDFS $196,000,000.00
  • Revenue This Year
  • EYPT N/A
  • PDFS $23.72
  • Revenue Next Year
  • EYPT N/A
  • PDFS $18.44
  • P/E Ratio
  • EYPT N/A
  • PDFS $1,002.51
  • Revenue Growth
  • EYPT 2.99
  • PDFS 17.76
  • 52 Week Low
  • EYPT $3.91
  • PDFS $15.91
  • 52 Week High
  • EYPT $14.37
  • PDFS $33.42
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 77.25
  • PDFS 46.51
  • Support Level
  • EYPT $11.38
  • PDFS $18.93
  • Resistance Level
  • EYPT $12.24
  • PDFS $20.54
  • Average True Range (ATR)
  • EYPT 0.74
  • PDFS 0.63
  • MACD
  • EYPT 0.13
  • PDFS 0.08
  • Stochastic Oscillator
  • EYPT 89.80
  • PDFS 60.00

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

Share on Social Networks: